Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4,090.00 |
|---|---|
| Enterprise Value | $1.50 Million |
| Earnings per Share | $-0.03 |
| Beta | 0.45 |
| Outstanding Shares | 10,225,376 |
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 15.45 |
| Enterprise Value to EBIT | -18.21 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.72 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its propr...